CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.
Asim PervaizMichael ZeppSaqib MahmoodDoaa Mohamed AliMartin R BergerHassan AdwanPublished in: Cellular oncology (Dordrecht) (2018)
Our findings indicate that targeting CCR5 may be an effective strategy to combat breast cancer bone metastasis.